Aligos Therapeutics, Inc. (ALGS)
2.15
-0.42
(-16.34%)
USD |
NASDAQ |
Nov 11, 16:00
2.09
-0.06
(-2.79%)
After-Hours: 19:46
Aligos Therapeutics Market Cap : 13.43M for Nov. 11, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 10, 2026 | 16.06M |
| November 09, 2026 | 24.68M |
| November 06, 2026 | 25.43M |
| November 05, 2026 | 28.18M |
| November 04, 2026 | 31.37M |
| November 03, 2026 | 29.68M |
| November 02, 2026 | 28.69M |
| October 30, 2026 | 29.94M |
| October 29, 2026 | 31.37M |
| October 28, 2026 | 32.24M |
| October 27, 2026 | 29.56M |
| October 26, 2026 | 29.00M |
| October 23, 2026 | 29.81M |
| October 22, 2026 | 30.06M |
| October 21, 2026 | 30.93M |
| October 20, 2026 | 31.37M |
| October 19, 2026 | 30.19M |
| October 16, 2026 | 30.31M |
| October 15, 2026 | 33.62M |
| October 14, 2026 | 32.62M |
| October 13, 2026 | 34.36M |
| October 12, 2026 | 34.49M |
| October 09, 2026 | 33.30M |
| October 08, 2026 | 33.12M |
| October 07, 2026 | 33.18M |
| Date | Value |
|---|---|
| October 06, 2026 | 33.55M |
| October 05, 2026 | 33.68M |
| October 02, 2026 | 34.55M |
| October 01, 2026 | 34.30M |
| September 30, 2026 | 35.11M |
| September 29, 2026 | 35.05M |
| September 28, 2026 | 34.55M |
| September 25, 2026 | 34.36M |
| September 24, 2026 | 34.61M |
| September 23, 2026 | 34.68M |
| September 22, 2026 | 35.42M |
| September 21, 2026 | 34.24M |
| September 18, 2026 | 32.68M |
| September 17, 2026 | 32.24M |
| September 16, 2026 | 31.50M |
| September 15, 2026 | 31.12M |
| September 14, 2026 | 31.43M |
| September 11, 2026 | 32.56M |
| September 10, 2026 | 33.24M |
| September 09, 2026 | 34.30M |
| September 08, 2026 | 35.92M |
| September 04, 2026 | 38.73M |
| September 03, 2026 | 38.79M |
| September 02, 2026 | 38.73M |
| September 01, 2026 | 37.98M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 325.95M |
| Amgen, Inc. | 253.20B |
| Anika Therapeutics, Inc. | 186.31M |
| BioCryst Pharmaceuticals, Inc. | 1.961B |
| Imunon, Inc. | 3.266M |
Market Cap Related Metrics
| PS Ratio | 0.6658 |
| Price to Book Value | 1.188 |
| Price | 2.15 |
| Earnings Yield | -296.0% |